Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Comment by jewel9mon Dec 16, 2016 8:19am

104 Views

Post# 25608912

RE:RE:Two Words

MirrorWorldMan wrote: well said Red, But its the white coats working with Geraldine that have the core competencies and focus in what they know best, stabilizing carbohydrates and finding new molecules. At some point the research arm is going to ask the sales and MA arms what they are bringing to the table. What are they doing with the products handed to them? Self praise by management on their experience is not a competence if there are no results. I am having trouble identifying what the management team is good at...seriously

Making embarassing video's and dedlines that are not met. Might be time for a change.

Bullboard Posts

From now on, dynaCERT instead of Bitcoin or NVIDIA?